Literature DB >> 24007177

Spatially resolved assessment of hepatic function using 99mTc-IDA SPECT.

Hesheng Wang1, Yue Cao.   

Abstract

PURPOSE: 99mTc-iminodiacetic acid (IDA) hepatobiliary imaging is usually quantified for hepatic function on the entire liver or regions of interest (ROIs) in the liver. The authors presented a method to estimate the hepatic extraction fraction (HEF) voxel-by-voxel from single-photon emission computed tomography (SPECT)∕CT with a 99mTc-labeled IDA agent of mebrofenin and evaluated the spatially resolved HEF measurements with an independent physiological measurement.
METHODS: Fourteen patients with intrahepatic cancers were treated with radiation therapy (RT) and imaged by 99mTc-mebrofenin SPECT before and 1 month after RT. The dynamic SPECT volumes were with a resolution of 3.9 × 3.9 × 2.5 mm(3). Throughout the whole liver with approximate 50 000 voxels, voxelwise HEF quantifications were estimated and compared between using arterial input function (AIF) from the heart and using vascular input function (VIF) from the spleen. The correlation between mean of the HEFs over the nontumor liver tissue and the overall liver function measured by Indocyanine green clearance half-time (T1∕2) was assessed. Variation of the voxelwise estimation was evaluated in ROIs drawn in relatively homogeneous regions of the livers. The authors also examined effects of the time range parameter on the voxelwise HEF quantification.
RESULTS: Mean of the HEFs over the liver estimated using AIF significantly correlated with the physiological measurement T1∕2 (r = 0.52, p = 0.0004), and the correlation was greatly improved by using VIF (r = 0.79, p < 0.0001). The parameter of time range for the retention phase did not lead to a significant difference in the means of the HEFs in the ROIs. Using VIF and a retention phase time range of 7-30 min, the relative variation of the voxelwise HEF in the ROIs was 10% ± 6% of respective mean HEF.
CONCLUSIONS: The voxelwise HEF derived from 99mTc-IDA SPECT by the deconvolution analysis is feasible to assess the spatial distribution of hepatic function in the liver.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24007177      PMCID: PMC3751955          DOI: 10.1118/1.4816655

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  22 in total

Review 1.  Tolerance of normal tissue to therapeutic irradiation.

Authors:  B Emami; J Lyman; A Brown; L Coia; M Goitein; J E Munzenrider; B Shank; L J Solin; M Wesson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

2.  Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients.

Authors:  A W Hemming; C H Scudamore; C R Shackleton; M Pudek; S R Erb
Journal:  Am J Surg       Date:  1992-05       Impact factor: 2.565

3.  Measurement of hepatocellular function with deconvolutional analysis: application in the differential diagnosis of acute jaundice.

Authors:  J E Juni; R Reichle
Journal:  Radiology       Date:  1990-10       Impact factor: 11.105

Review 4.  Pharmacokinetics and clinical application of technetium 99m-labeled hepatobiliary agents.

Authors:  G T Krishnamurthy; F E Turner
Journal:  Semin Nucl Med       Date:  1990-04       Impact factor: 4.446

5.  Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves.

Authors:  P H Brown; J E Juni; D A Lieberman; G T Krishnamurthy
Journal:  J Nucl Med       Date:  1988-05       Impact factor: 10.057

6.  Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy.

Authors:  Hesheng Wang; Mary Feng; Kirk A Frey; Randall K Ten Haken; Theodore S Lawrence; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-05-18       Impact factor: 7.038

7.  Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man.

Authors:  M E Gottlieb; H H Stratton; J C Newell; D M Shah
Journal:  Arch Surg       Date:  1984-03

8.  Analysis of radiation-induced liver disease using the Lyman NTCP model.

Authors:  Laura A Dawson; Daniel Normolle; James M Balter; Cornelius J McGinn; Theodore S Lawrence; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

9.  Quantification of hepatobiliary function as an integral part of imaging with technetium-99m-mebrofenin in health and disease.

Authors:  E Doo; G T Krishnamurthy; M J Eklem; S Gilbert; P H Brown
Journal:  J Nucl Med       Date:  1991-01       Impact factor: 10.057

10.  The role of Tc-99m IDA hepatobiliary and Tc-99m colloid hepatic imaging in primary biliary cirrhosis.

Authors:  T Aburano; K Yokoyama; N Shuke; S Kinuya; T Takayama; N Tonami; K Hisada
Journal:  Clin Nucl Med       Date:  1991-01       Impact factor: 7.794

View more
  3 in total

1.  Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients.

Authors:  Stephen R Bowen; Jatinder Saini; Tobias R Chapman; Robert S Miyaoka; Paul E Kinahan; George A Sandison; Tony Wong; Hubert J Vesselle; Matthew J Nyflot; Smith Apisarnthanarax
Journal:  Radiother Oncol       Date:  2015-04-28       Impact factor: 6.280

2.  Functional Liver Imaging in Radiotherapy for Liver Cancer: A Systematic Review and Meta-Analysis.

Authors:  Pi-Xiao Zhou; Ying Zhang; Quan-Bin Zhang; Guo-Qian Zhang; Hui Yu; Shu-Xu Zhang
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

3.  Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients.

Authors:  Stephen R Bowen; Tobias R Chapman; Joshua Borgman; Robert S Miyaoka; Paul E Kinahan; Iris W Liou; George A Sandison; Hubert J Vesselle; Matthew J Nyflot; Smith Apisarnthanarax
Journal:  EJNMMI Res       Date:  2016-06-27       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.